Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
3 Biotech Stocks With Massive Upside to Buy Before August Starts
08:00am, Wednesday, 29'th Jul 2026
Biotech is setting up as one of the more interesting risk-on trades heading into the back half of 2026.
Dimensional Fund Advisors LP Buys 343,216 Shares of Moderna, Inc. $MRNA
03:39am, Wednesday, 29'th Jul 2026
Dimensional Fund Advisors LP lifted its position in Moderna, Inc. (NASDAQ: MRNA) by 19.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Excha
2 Major Reasons to Buy Moderna Stock Before July 31
12:21pm, Tuesday, 28'th Jul 2026
Moderna (NASDAQ:MRNA | MRNA Price Prediction) enters a critical six-day stretch with Q2 earnings due July 31, and an FDA decision on its seasonal flu vaccine expected August 5.
Moderna (MRNA) Laps the Stock Market: Here's Why
06:51pm, Monday, 27'th Jul 2026
In the most recent trading session, Moderna (MRNA) closed at $55.63, indicating a +2.89% shift from the previous trading day.
After Soaring Nearly 90% Thus Far in 2026, Is Moderna's Stock Still a Buy?
04:02pm, Monday, 27'th Jul 2026
Moderna's stock recently hit a new 52-week high after receiving positive news surrounding one of its vaccines.
Moderna: A Stock to Watch or a Risky Bet?
07:00pm, Friday, 24'th Jul 2026
Explore the exciting world of Moderna (MRNA -5.17%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends
Will Moderna (MRNA) Report Negative Earnings Next Week? What You Should Know
11:01am, Friday, 24'th Jul 2026
Moderna (MRNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
California Public Employees Retirement System Purchases 149,192 Shares of Moderna, Inc. $MRNA
04:17am, Wednesday, 22'nd Jul 2026
California Public Employees Retirement System raised its position in Moderna, Inc. (NASDAQ: MRNA) by 31.1% during the undefined quarter, according to its most recent filing with the Securities and Exc
Should You Buy Moderna Stock Hand Over Fist Before Aug. 5?
08:00pm, Tuesday, 21'st Jul 2026
Moderna is racing towards an important approval. But it may not move the stock higher.
IXJ vs. RSPH: Which Healthcare ETF Is the Better Buy?
01:32pm, Tuesday, 21'st Jul 2026
IXJ offers a higher dividend yield and lower volatility with global exposure, while RSPH's equal-weight approach posted a stronger 1-year return.
Moderna (MRNA) Suffers a Larger Drop Than the General Market: Key Insights
06:51pm, Monday, 20'th Jul 2026
In the most recent trading session, Moderna (MRNA) closed at $59.49, indicating a -3.77% shift from the previous trading day.
Moderna Is Up 109% in 2026. Jim Cramer Just Called It 'Finally Investable Again.
06:10pm, Monday, 20'th Jul 2026
Moderna is known as a coronavirus vaccine giant, but it's progressively becoming a multi-product company. The biotech has several exciting candidates in late-stage trials.
MRNA Advances Cancer Pipeline With New Immunotherapy Study
12:01pm, Friday, 17'th Jul 2026
Moderna doses the first U.S. participant in a phase I study of mRNA-4200, advancing its off-the-shelf cancer therapy pipeline beyond vaccines.
CAMBRIDGE, MA / ACCESS Newswire / July 16, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced the dosing of the first U.S. participant in its Phase 1 study evaluating mRNA-4200, a tumor-targeted cance
Moderna set for uneventful Q2 report ahead of key data readouts, says Jefferies
01:37pm, Tuesday, 14'th Jul 2026
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) is expected to report second quarter results on July 31, with investors focused on the impact of seasonal COVID-19 vaccine demand and updates on the company's late
